†
HR 4818 EAS
ing Capital Fund (in this section referred to as the ‘‘HIV/
AIDS Fund’’).
(b) Funds deposited during any fiscal year in the HIV/
AIDS Fund shall be available without fiscal year limitation
and used for pharmaceuticals and other products needed to
provide care and treatment of persons with HIV/AIDS and
related infections, including, but not limited to—
(1) anti-retroviral drugs;
(2) other pharmaceuticals and medical items
needed to provide care and treatment to persons with
HIV/AIDS and related infections;
(3) laboratory and other supplies for performing
tests related to the provision of care and treatment to
persons with HIV/AIDS and related infections;
(4) other medical supplies needed for the oper-
ation of HIV/AIDS treatment and care centers, in-
cluding products needed in programs for the preven-
tion of mother-to-child transmission;
(5) pharmaceuticals and health commodities
needed for the provision of palliative care; and
(6) laboratory and clinical equipment, as well as
equipment needed for the transportation and care of
HIV/AIDS supplies, and other equipment needed to
provide prevention, care and treatment of HIV/AIDS
described above.
†
HR 4818 EAS
(c) There may be deposited during any fiscal year in
the HIV/AIDS Fund payments for HIV/AIDS pharma-
ceuticals and products provided from the HIV/AIDS Fund
received from applicable appropriations and funds of the
United States Agency for International Development, the
Department of Health and Human Services, the Depart-
ment of Defense, or other Federal agencies and other sources
at actual cost of the HIV/AIDS pharmaceuticals and other
products, actual cost plus the additional costs of providing
such HIV/AIDS pharmaceuticals and other products, or at
any other price agreed to by the Coordinator or his designee.
(d) There may be deposited in the HIV/AIDS Fund
payments for the loss of, or damage to, HIV/AIDS pharma-
ceuticals and products held in the HIV/AIDS Fund, rebates,
reimbursements, refunds and other credits application to
the operation of the HIV/AIDS Fund.
(e) At the close of each fiscal year the Coordinator may
transfer out of the HIV/AIDS Fund to other HIV/AIDS
programmatic areas such amounts as the Coordinator de-
termines to be in excess of the needs of the HIV/AIDS Fund.
(f) At the close of each fiscal year the Coordinator shall
submit a report to the Committees on Appropriations de-
tailing the financial activities of the HIV/AIDS Fund, in-
cluding sources of income and information regarding dis-
bursements.
†
HR 4818 EAS
DEMOCRACY PROGRAMS
SEC. 5026. (a) Notwithstanding any other provision
of law, of the funds appropriated by this Act to carry out
the provisions of chapter 4 of part II of the Foreign Assist-
ance Act of 1961, not less than $35,000,000 shall be made
available for assistance for activities to support democracy,
human rights, and the rule of law in the People’s Republic
of China and Hong Kong: Provided, That funds appro-
priated under the heading ‘‘Economic Support Fund’’
should be made available for assistance for Taiwan for the
purposes of furthering political and legal reforms: Provided
further, That such funds shall only be made available to
the extent that they are matched from sources other than
the United States Government: Provided further, That
funds made available pursuant to the authority of this sub-
section shall be subject to the regular notification procedures
of the Committees on Appropriations.
(b)(1) In addition to the funds made available in sub-
section (a), of the funds appropriated by this Act under the
heading ‘‘Economic Support Fund’’ not less than
$25,000,000 shall be made available for programs and ac-
tivities to foster democracy, human rights, civic education,
women’s development, press freedom, and the rule of law
in countries with a significant Muslim population, and
where such programs and activities would be important to